Democrats see Bernie Sanders as leader in healthcare debate

Democrats and Democratic-leaning independents favor Bernie Sanders when it comes to who can best handle healthcare out of the field of Democratic candidates for president, according to a CNN poll. Sanders, along with several other candidates, supports Medicare for all.

The poll came after the first two Democratic presidential debates, which aired in the last week of June.

Out of the top Democratic candidates, 26% of Democrats and Democratic-leaning independents queried by CNN support Sanders, 18% supported Vice President Joe Biden, followed by Massachusetts Sen. Elizabeth Warren (16%), and California Sen. Kamala Harris (16%).

The poll also revealed about half of this group of voters also want a Medicare for all plan, but don’t want to eradicate private insurance entirely––57% said the government should not completely replace private health insurance.

Among those who said they wanted both a national insurance plan and the elimination of private insurance, 36% supported Sanders as the best candidate to handle healthcare. He still was the top supported candidate, with 27% of participant selection, for those who wanted a national healthcare plan without the elimination of private insurance. Harris had 13% of support from this group.

Overall, 56% of voters in the poll said they support a government-sponsored health insurance program for all Americans, even with higher taxes, compared to 40% who did not.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.